Latest developments in metal complexes as anticancer agents
R Paprocka, M Wiese-Szadkowska… - Coordination Chemistry …, 2022 - Elsevier
Every year novel biologically active compounds are designed as antitumor agents. This
review covers and highlights some of the most important findings described during 2018 …
review covers and highlights some of the most important findings described during 2018 …
Recent developments on other platinum metal complexes as target-specific anticancer therapeutics
TS Prathima, B Choudhury, MG Ahmad… - Coordination Chemistry …, 2023 - Elsevier
Numerous biologically active metal complexes are reported for their unique features and
enhanced functions, particularly towards the inhibition of cancer progression. With the …
enhanced functions, particularly towards the inhibition of cancer progression. With the …
[HTML][HTML] Recent advances in nanocarrier-assisted therapeutics delivery systems
S Su, PM Kang - Pharmaceutics, 2020 - mdpi.com
Nanotechnologies have attracted increasing attention in their application in medicine,
especially in the development of new drug delivery systems. With the help of nano-sized …
especially in the development of new drug delivery systems. With the help of nano-sized …
Niosomes: a novel targeted drug delivery system for cancer
M Moghtaderi, K Sedaghatnia, M Bourbour… - Medical Oncology, 2022 - Springer
Recently, nanotechnology is involved in various fields of science, of which medicine is one
of the most obvious. The use of nanoparticles in the process of treating and diagnosing …
of the most obvious. The use of nanoparticles in the process of treating and diagnosing …
Target based chemotherapeutic advancement of ruthenium complexes
BK Kundu, S Mukhopadhyay - Coordination Chemistry Reviews, 2021 - Elsevier
Over the last few years, great emphasis has been given to develop ruthenium complexes to
act as target specified chemotherapeutic agents. Indeed, there are few reviews available …
act as target specified chemotherapeutic agents. Indeed, there are few reviews available …
Bioactivity and development of small non-platinum metal-based chemotherapeutics
Countless expectations converge in the multidisciplinary endeavour for the search and
development of effective and safe drugs in fighting cancer. Although they still embody a …
development of effective and safe drugs in fighting cancer. Although they still embody a …
Ruthenium complexes as promising candidates against lung cancer
Q Sun, Y Li, H Shi, Y Wang, J Zhang, Q Zhang - Molecules, 2021 - mdpi.com
Lung cancer is one of the most common malignancies with the highest mortality rate and the
second-highest incidence rate after breast cancer, posing a serious threat to human health …
second-highest incidence rate after breast cancer, posing a serious threat to human health …
Ruthenium complexes: An alternative to platinum drugs in colorectal cancer treatment
Colorectal cancer (CRC) is one of the intimidating causes of death around the world. CRC
originated from mutations of tumor suppressor genes, proto-oncogenes and DNA repair …
originated from mutations of tumor suppressor genes, proto-oncogenes and DNA repair …
Review of comparative studies of cytotoxic activities of Pt (II), Pd (II), Ru (II)/(III) and Au (III) complexes, their kinetics of ligand substitution reactions and DNA/BSA …
New concepts and various strategies are being explored to improve the cytotoxicity of metal-
based complexes. One of those strategies is to fine-tune the substitution kinetics of metallo …
based complexes. One of those strategies is to fine-tune the substitution kinetics of metallo …
Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases
C Riccardi, F Napolitano, D Montesarchio, S Sampaolo… - Pharmaceutics, 2021 - mdpi.com
Neurodegenerative diseases (NDs) represent a heterogeneous group of aging-related
disorders featured by progressive impairment of motor and/or cognitive functions, often …
disorders featured by progressive impairment of motor and/or cognitive functions, often …